| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Johnson & Johnson (JNJ) has 22 insiders with recent SEC Form 4 filings, including 2 buys and 4 sells. JNJ is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.04M | $934.61M | - | |
| VP | 193.5K | $44.77M | - | |
| VP | 46.2K | $10.69M | - | |
| VP | 34.7K | $8.02M | - | |
| CEO | 30.9K | $7.14M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 23, 2015 | Kapusta Ronald A | Controller, CAO | Sale+OE | 6,239 | $99.68 | $621,903.52 | -23.1% | |
| Aug 6, 2015 | Prince Charles | Director | Buy | 2,500 | $99.25 | $248,131.50 | +10.8% | |
| Jun 8, 2015 | Johnson & Johnson59 | 10% Owner | Sell | 1,010,265 | $47.94 | $48,432,104.10 | -32.8% | |
| Jun 2, 2015 | Prince Charles | Director | Buy | 2,500 | $99.22 | $248,050.00 | +12.1% | |
| Apr 28, 2015 | Stoffels Paulus | Chief Scientific Officer | Sale+OE | 187,250 | $100.73 | $18,862,141.90 | -66.5% | |
| Mar 5, 2015 | Fasolo Peter61 | VP, Global Human Resources | Sale+OE | 115,307 | $102.40 | $11,807,863.44 | -78.0% |